
M&A Advisory Firm
New York, New York HQ








Topix Pharmaceuticals
New Mountain Capital LLC
June 2016

Cardiome Pharma Corp.
Allergan, Plc
April 2016

The Female Health Company
Aspen Park Pharmaceuticals, Inc
April 2016

Acerus Pharmaceuticals Corporation
Aytu BioScience, Inc
March 2016

Eisai Inc.
PBM Capital Group
March 2016

Private Spec Pharma
Undisclosed
February 2016

Cambrooke Therapeutics
Undisclosed
January 2016

Amerigen Pharmaceuticals Inc
Undisclosed
December 2015

PhosImmune Inc.
Agenus Inc
December 2015

Dara Biosciences Inc
Midatech Pharma
November 2015

Mimetogen Pharmaceuticals Inc
Allergan, Plc
October 2015

XOMA Ltd.
Novartis
October 2015

IGI Laboratories, Inc
Alveda Pharmaceuticals Inc
October 2015

Crown Laboratories
Hayfin Capital
September 2015

Crown Laboratories, Inc
Hayfin Capital Management LLP
September 2015

OctreoPharm
Ipsen
July 2015

cCAM
Merck
July 2015

Teva Pharmaceutical Industries
ANI Pharmaceuticals, Inc
June 2015

Ipsen Innovation for patient care
OctreoPharma Sciences
May 2015

arGen-X
Leo Pharmaceuticals
April 2015

Phenex Pharmaceuticals AG
Gilead Sciences, Inc.
January 2015

Rimsa
Teva Pharmaceutical Industries
January 2015

PDI, Inc.
Undisclosed
October 2014

RedPath Integrated Pathology
PDI, Inc.
October 2014

Innovative Therapies
Cardinal Health, Inc. (NYSE:CAH)
September 2014

Fibrotech Theraputics
Shire Plc
July 2014

Trimel Pharmaceuticals Corporation
Undisclosed
July 2014

Compugen
Undisclosed
January 2014

Correvio International
Cardiome Pharma Corp.
November 2013
Join Axial's Private M&A Platform
Torreya Partners connects with qualified M&A advisors through the Axial Platform.
Selling Your Company?
Find the perfect advisor to help you sell your business.
Find Deals
Grow your deal flow without more headcount.






